🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Van Morris, MD Daniel Haldar ASCO MD Anderson Cancer Center We would like to inform you that your post has been published on @Oncodaily. Thank you for sharing! oncodaily.com/blog/232482

Look forward to presenting results from our pilot study of a personalized neoantigen vaccine +/- pembrolizumab for patients with metastatic pMMR/MSS colorectal cancer. Tomorrow 3-5 pm at the ADCs and Immuno-Oncology Clinical Trials Minisymposium #AACR25 MD Anderson Cancer Center

At #AACR25, Dr. Daniel Haldar presented results from a feasibility study that combined a personalized vaccine with and without pembrolizumab immunotherapy in patients with microsatellite-stable metastatic colorectal cancer. Read more: bit.ly/4jqFqoR Daniel Haldar

WATCH: S. Daniel Haldar, MD, discusses outcomes for NeoAg-Vax with or without pembrolizumab in MSS metastatic colorectal cancer. Daniel Haldar MD Anderson Cancer Center Johns Hopkins Medicine AACR #AACR25 #crcsm #oncology onclive.com/view/dr-haldar…

Thank you to Daniel Haldar of MD Anderson Cancer Center for joining us at #AACR25 to discuss CT012 personalized neoantigen vaccine with/without pembrolizumab in microsatellite-stable metastatic colorectal cancer. Want more insights from AACR? Check out our site: onclive.com/conference/aacr

It's time for the #FiveUnder5 🕓, your go-to roundup of the top 5 #oncology videos of the week. Check out the clips that made the list 🔗: onclive.com/view/five-unde… Daniel Haldar MD Anderson Cancer Center Ospedale San Raffaele UF Medicine Chad Tang, MD Joe Jacob MD, MCR Upstate Medical University

Honored to be named a #40Under40 in Cancer awardee!! Grateful for the recognition of #patienteducation as a vital part of lung cancer care. HUGE congratulations to my fellow awardees—can’t wait to celebrate together in Chicago! #ASCO25

Huge week for GI Medical Oncology MD Anderson Cancer Center with not one - but TWO - NEJM articles published by our group. Perfect start to #ASCO25! 1️⃣ Beautiful review on the unique biology and treatment of cancer of unknown primary (CUP) authored by our own Dr. Kanwal Raghav 🩺 🖖🏻

More oxaliplatin or irinotecan likely not the answer for MRD+ CRC. We need to investigate novel approaches - vaccines, cellular therapies, bispecifics etc - in this setting to make a difference #crcsm #ASCO25

On Sunday, June 1, Drs. Daniel Haldar and Scott Kopetz will be in booth 10059 at #ASCO25 at 10 a.m. to share the latest in colorectal cancer management. Learn more about disease symptoms, diagnosis and treatment: bit.ly/3YTlLpB#EndCan… (1/6) Daniel Haldar Scott Kopetz

Always great to see Marina Baretti who is doing impactful work in hepatobiliary cancers including the rare fibrolamellar subtype #ASCO25

This #ASCO was special as it was a celebration of success of our Junior Faculty and fellows who SHOWED UP!!! Officially in the ranks of “Senior Author” 😄😄😄 #endcancer ASCO MD Anderson Cancer Center

New headshot. Same mission: #EndCancer (and finish these manuscripts...) MD Anderson Cancer Center

Paulo Amaral, MD Brian Rini, MD Integrity CE, LLC Rana McKay, MD, FASCO Sumanta K. Pal, MD, FASCO Katy Beckermann Joseph Vento, MD, MS Miguel Zugman Toni Choueiri, MD Tom Powles Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) KidneyCAN 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 jc Alan Tan Uromigos Laurence Albiges Andrey Soares Sahil Doshi Gabriel Aleixo James Brugarolas Yu-Wei Chen, MD, MS Hans Hammers #TumorBoardTuesday I hope everyone in the US🇺🇸is able to enjoy a peaceful and festive 4th of July🎆 📢Then we'll see you back here 07/08/2025 as the omnipresent & infamous Dr. Shubham Pant and the⬆️⭐️Daniel Haldar from MD Anderson Cancer Center 🗣️treatment options in #PancreaticCancer

#TumorBoardTuesday 😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer So to put this in context: 📢Join us Tuesday, 07-08-25 at 8PM ET as Dr. Shubham Pant & Daniel Haldar 🗣️Optimizing 1L Treatment Selection in mPDAC RT and bring others into the discussion‼️

Dr. Shubham Pant Daniel Haldar Mike Pishvaian Brandon Smaglo Dr. Neeha Zaidi Rohit Thummalapalli Nicholas Hornstein Shruti Patel, MD Ryan Huey, MD, MS Saumya Maru M.D., Ph.D. Madhu Eluri, MD Ethan Ludmir MD A pancreatic cancer doctor Tanios Bekaii-Saab, MD Wungki Park, MD MS Mark Lewis, MD, FASCO Anirban Maitra Arndt Vogel Oncology Brothers #TumorBoardTuesday Amazing summary Dr. Shubham Pant and Daniel Haldar I could barely keep up with all the back and forth - thank you for making this so engaging and motivating‼️